The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effects of Phosphate Binders in Moderate CKD
Open accessAbstract
Some propose using phosphate binders in the CKD population given the association between higher levels of phosphorus and mortality, but their safety and efficacy in this population are not well understood. Here, we aimed to determine the effects of phosphate binders on parameters of mineral metabolism and vascular calcification among patients with moderate to advanced CKD. We randomly assigned 148 patients with estimated GFR=20-45 ml/min per 1.73 m(2) to calcium acetate, lanthanum carbonate, sevelamer carbonate, or placebo. The primary endpoint was change in mean serum phosphorus from baseline to the average of months 3, 6, and 9. Serum phosphorus decreased from a baseline mean of 4.2 mg/dl in both active and placebo arms to 3.9 mg/dl with active therapy and 4.1 mg/dl with placebo (P=0.03). Phosphate binders, but not placebo, decreased mean 24-hour urine phosphorus by 22%. Median serum intact parathyroid hormone remained stable with active therapy and increased with placebo (P=0.002). Active therapy did not significantly affect plasma C-terminal fibroblast growth factor 23 levels. Active therapy did, however, significantly increase calcification of the coronary arteries and abdominal aorta (coronary: median increases of 18.1% versus 0.6%, P=0.05; abdominal aorta: median increases of 15.4% versus 3.4%, P=0.03). In conclusion, phosphate binders significantly lower serum and urinary phosphorus and attenuate progression of secondary hyperparathyroidism among patients with CKD who have normal or near-normal levels of serum phosphorus; however, they also promote the progression of vascular calcification. The safety and efficacy of phosphate binders in CKD remain uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Self-citationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
Self-citationFGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
(2003) · PubMed · Cited by 1,372
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationSerum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Self-citationIsakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G. (2005) · Circulation · doi:10.1161/circulationaha.105.553198 · Cited by 885
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Self-citationCallister, T. Q., Raggi, P., Cooil, B., Lippolis, N. J., & Russo, D. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392703 · Cited by 682
Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
Kalantar-Zadeh, K., Gutekunst, L., Mehrotra, R., Kovesdy, C. P., Bross, R., Shinaberger, C. S., Noori, N., Hirschberg, R., Benner, D., Nissenson, A. R., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06080809 · Cited by 510
Progression of Coronary Artery Calcium Predicts All-Cause Mortality
Budoff, M. J., Hokanson, J. E., Nasir, K., Shaw, L. J., Kinney, G. L., Chow, D., DeMoss, D., Nuguri, V., Nabavi, V., Ratakonda, R., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.08.018 · Cited by 475
Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
Burnett, S.-A. M., Gunawardene, S. C., Bringhurst, F. R., Jüppner, H., Lee, H., & Finkelstein, J. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060507 · Cited by 455
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357
Intestinal Npt2b Plays a Major Role in Phosphate Absorption and Homeostasis
Sabbagh, Y., O'Brien, S. P., Song, W., Boulanger, J. H., Stockmann, A., Arbeeny, C., & Schiavi, S. C. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050559 · Cited by 346
Hasegawa, H., Nagano, N., Urakawa, I., Yamazaki, Y., Iijima, K., Fujita, T., Yamashita, T., Fukumoto, S., & Shimada, T. (2010) · Kidney International · doi:10.1038/ki.2010.313 · Cited by 341
Russo, D., Miranda, I., Ruocco, C., Battaglia, Y., Buonanno, E., Manzi, S., Russo, L., Scafarto, A., & Andreucci, V. E. (2007) · Kidney International · doi:10.1038/sj.ki.5002518 · Cited by 334
Foley, R. N., Collins, A. J., Ishani, A., & Kalra, P. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.016 · Cited by 274
Portale, A. A., Halloran, B. P., & Morris, R. C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113172 · Cited by 234
Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition
Zoccali, C., Ruggenenti, P., Perna, A., Leonardis, D., Tripepi, R., Tripepi, G., Mallamaci, F., & Remuzzi, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011020175 · Cited by 210
Hokanson, J. E., MacKenzie, T., Kinney, G., Snell-Bergeon, J. K., Dabelea, D., Ehrlich, J., Eckel, R. H., & Rewers, M. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.5.1821327 · Cited by 207
Spiegel, D. M., & Brady, K. (2012) · Kidney International · doi:10.1038/ki.2011.490 · Cited by 201
Self-citationIsakova, T., Gutierrez, O. M., Smith, K., Epstein, M., Keating, L. K., Juppner, H., & Wolf, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq419 · Cited by 165
Self-citationYılmaz, M. İ., Sönmez, A., Sağlam, M., Yaman, H., Kılıç, S., Eyileten, T., Çağlar, K., Oğuz, Y., Vural, A., Yenicesu, M., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.007 · Cited by 140
Stubbs, J. R., He, N., Idiculla, A., Gillihan, R., Liu, S., David, V., Hong, Y., & Quarles, L. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.516 · Cited by 117
Outcomes Associated With Phosphorus Binders in Men With Non–Dialysis-Dependent CKD
Kovesdy, C. P., Kuchmak, O., Lü, J., & Kalantar‐Zadeh, K. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.06.011 · Cited by 86
Chue, C. D., Edwards, N. C., Moody, W. E., Steeds, R. P., Townend, J., & Ferro, C. J. (2011) · Heart · doi:10.1136/heartjnl-2011-300570 · Cited by 79
Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b+/−mice
Ohi, A., Hanabusa, E., Ueda, O., Segawa, H., Horiba, N., Kaneko, I., Kuwahara, S., Mukai, T., Sasaki, S., Tominaga, R., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00663.2010 · Cited by 47
Drüeke, T. B., & Massy, Z. A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012060569 · Cited by 28
Cited by
(2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.04.001 · Cited by 1,956
Jamal, S. A., Vandermeer, B., Raggi, P., Mendelssohn, D. C., Chatterley, T., Dorgan, M., Lok, C. E., Fitchett, D., & Tsuyuki, R. T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60897-1 · Cited by 435
Isakova, T., Nickolas, T. L., Denburg, M., Yarlagadda, S., Weiner, D. E., Gutiérrez, O. M., Bansal, V., Rosas, S. E., Nigwekar, S., Yee, J., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.07.019 · Cited by 373
Ketteler, M., Block, G. A., Evenepoel, P., Fukagawa, M., Herzog, C. A., McCann, L., Moe, S. M., Shroff, R., Tonelli, M. A., Toussaint, N. D., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2640 · Cited by 318
Self-citationVascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Yamada, S., & Giachelli, C. M. (2017) · Bone · doi:10.1016/j.bone.2016.11.012 · Cited by 316
Metadata
- Authors
- Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B., Ketteler, M., Spiegel, D. M., Allison, M. A., Asplin, J., Smits, G., Hoofnagle, A. N., Kooienga, L., Thadhani, R., Mannstadt, M., Wolf, M., & Chertow, G. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-08
- Volume
- 23
- Issue
- 8
- Pages
- 1407-1415
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2102734552
- Cited by
- 540
- References
- 31
- FWCI
- 39.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.